Table 2. Summary of overall results for MYXV, vvDD, and MRBV oncolytic efficacy in ovarian cancer adherent cells and spheroids.
HEYA8 |
SKOV3 |
OVCAR8 |
||||
---|---|---|---|---|---|---|
ADH | SPH | ADH | SPH | ADH | SPH | |
MYXV | ++ | − | ++ | − | ++ | − |
vvDD | ++ | + | ++ | − | ++ | ++ |
MRBV | ++++ | +++ | ++++ | +++ | ++++ | + |
ADH, adherent cells; MYXV, Myxoma virus; SPH, spheroids.